(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
@ $3.36
Issued: 14 Feb 2024 @ 13:54
Return: 12.37%
Previous signal: Feb 14 - 09:30
Previous signal:
Return: 4.19 %
Live Chart Being Loaded With Signals
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis...
Stats | |
---|---|
Today's Volume | 386 337 |
Average Volume | 575 187 |
Market Cap | 223.99M |
EPS | $-0.0800 ( 2024-05-02 ) |
Next earnings date | ( $-0.110 ) 2024-06-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.39 |
ATR14 | $0.00500 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Machatha Stephen | Sell | 11 537 | Common Stock |
2024-03-11 | Greenberg Bruce | Sell | 13 201 | Common Stock |
2024-04-05 | Perceptive Advisors Llc | Buy | 37 712 | Common Stock |
2024-04-04 | Perceptive Advisors Llc | Buy | 140 281 | Common Stock |
2024-04-03 | Perceptive Advisors Llc | Buy | 309 847 | Common Stock |
INSIDER POWER |
---|
16.83 |
Last 100 transactions |
Buy: 8 132 048 | Sell: 3 580 213 |
Volume Correlation
Aldeyra Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
SVVC | 0.96 |
BOCH | 0.96 |
ACCD | 0.956 |
VORB | 0.955 |
AEZS | 0.955 |
VIAV | 0.955 |
PHCF | 0.954 |
LMDX | 0.954 |
NEOG | 0.952 |
CTHR | 0.952 |
10 Most Negative Correlations | |
---|---|
ORTX | -0.975 |
DLHC | -0.959 |
ISTR | -0.957 |
RETA | -0.953 |
THRN | -0.953 |
ESSA | -0.949 |
FRBK | -0.948 |
FMIV | -0.946 |
INO | -0.945 |
DAWN | -0.944 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aldeyra Therapeutics Inc Correlation - Currency/Commodity
Aldeyra Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-262 780 (0.00 %) |
EPS: | $-0.640 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-262 780 (0.00 %) |
EPS: | $-0.640 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-258 707 (0.00 %) |
EPS: | $-1.050 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.070 |
Financial Reports:
No articles found.
Aldeyra Therapeutics Inc
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators